Dr. Amy Abernethy

Dr. Amy Abernethy 540 540 Doug DeMarra

“As we explore how robust analyses of real-world data can inform FDA’s response to COVID-19, partners like HealthVerity will help us to identify and evaluate data sources that can be used to answer crucial questions, like how COVID-19 affects different patient populations.”